Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review

Preliminary evidence supports the use of psychedelics for major depressive disorder (MDD). However, less attention has been given to the neural mechanisms behind their effects. We conducted a systematic review examining the neuroimaging correlates of antidepressant response following psychedelic int...

Full description

Bibliographic Details
Main Authors: Sarah Kuburi, Anne-Marie Di Passa, Vanessa K. Tassone, Raesham Mahmood, Aleksandra Lalovic, Karim S. Ladha, Katharine Dunlop, Sakina Rizvi, Ilya Demchenko, Venkat Bhat
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Chronic Stress
Online Access:https://doi.org/10.1177/24705470221115342
_version_ 1811265193006596096
author Sarah Kuburi
Anne-Marie Di Passa
Vanessa K. Tassone
Raesham Mahmood
Aleksandra Lalovic
Karim S. Ladha
Katharine Dunlop
Sakina Rizvi
Ilya Demchenko
Venkat Bhat
author_facet Sarah Kuburi
Anne-Marie Di Passa
Vanessa K. Tassone
Raesham Mahmood
Aleksandra Lalovic
Karim S. Ladha
Katharine Dunlop
Sakina Rizvi
Ilya Demchenko
Venkat Bhat
author_sort Sarah Kuburi
collection DOAJ
description Preliminary evidence supports the use of psychedelics for major depressive disorder (MDD). However, less attention has been given to the neural mechanisms behind their effects. We conducted a systematic review examining the neuroimaging correlates of antidepressant response following psychedelic interventions for MDD. Through MEDLINE, Embase, and APA PsycINFO, 187 records were identified and 42 articles were screened. Six published studies and one conference abstract were included. Five ongoing trials were included from ClinicalTrials.gov. Our search covered several psychedelics, though included studies were specific to psilocybin, ayahuasca, and lysergic acid diethylamide. Three psilocybin studies noted amygdala activity and functional connectivity (FC) alterations that correlated with treatment response. Two psilocybin studies reported that FC changes in the medial and ventromedial prefrontal cortices correlated with treatment response. Two trials from a single study reported global decreases in brain network modularity which correlated with antidepressant response. One ayahuasca study reported increased activity in the limbic regions following treatment. Preliminary evidence suggests that the default mode and limbic networks may be a target for future research on the neural mechanisms of psychedelics. More data is required to corroborate these initial findings as the evidence summarized in this review is based on four datasets.
first_indexed 2024-04-12T20:18:01Z
format Article
id doaj.art-54c8022031ca41e8a6fa9394db1b9f42
institution Directory Open Access Journal
issn 2470-5470
language English
last_indexed 2024-04-12T20:18:01Z
publishDate 2022-07-01
publisher SAGE Publishing
record_format Article
series Chronic Stress
spelling doaj.art-54c8022031ca41e8a6fa9394db1b9f422022-12-22T03:18:04ZengSAGE PublishingChronic Stress2470-54702022-07-01610.1177/24705470221115342Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic ReviewSarah Kuburi0Anne-Marie Di Passa1Vanessa K. Tassone2Raesham Mahmood3Aleksandra Lalovic4Karim S. Ladha5Katharine Dunlop6Sakina Rizvi7Ilya Demchenko8Venkat Bhat9 Interventional Psychiatry Program, Mental Health and Addictions Service, St. Michael’s Hospital, 193 Yonge Street 6-013, M5B 1M8, Toronto, Ontario, Canada Interventional Psychiatry Program, Mental Health and Addictions Service, St. Michael’s Hospital, 193 Yonge Street 6-013, M5B 1M8, Toronto, Ontario, Canada Interventional Psychiatry Program, Mental Health and Addictions Service, St. Michael’s Hospital, 193 Yonge Street 6-013, M5B 1M8, Toronto, Ontario, Canada Institute of Medical Science, Faculty of Medicine, , 1 King's College Circle, Medical Sciences Building, M5S 1A8, Toronto, Ontario, Canada Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 209 Victoria Street, M5B 1T8, Toronto, Ontario, Canada Department of Anesthesia, St. Michael's Hospital, 193 Yonge Street 6-013, M5B 1M8, Toronto, Ontario, Canada Keenan Research Center for Biomedical Science, St. Michael’s Hospital, Unity Health Toronto, 30 Bond Street, M5B 1W8, Toronto, Ontario, Canada Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 209 Victoria Street, M5B 1T8, Toronto, Ontario, Canada Interventional Psychiatry Program, Mental Health and Addictions Service, St. Michael’s Hospital, 193 Yonge Street 6-013, M5B 1M8, Toronto, Ontario, Canada Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 209 Victoria Street, M5B 1T8, Toronto, Ontario, CanadaPreliminary evidence supports the use of psychedelics for major depressive disorder (MDD). However, less attention has been given to the neural mechanisms behind their effects. We conducted a systematic review examining the neuroimaging correlates of antidepressant response following psychedelic interventions for MDD. Through MEDLINE, Embase, and APA PsycINFO, 187 records were identified and 42 articles were screened. Six published studies and one conference abstract were included. Five ongoing trials were included from ClinicalTrials.gov. Our search covered several psychedelics, though included studies were specific to psilocybin, ayahuasca, and lysergic acid diethylamide. Three psilocybin studies noted amygdala activity and functional connectivity (FC) alterations that correlated with treatment response. Two psilocybin studies reported that FC changes in the medial and ventromedial prefrontal cortices correlated with treatment response. Two trials from a single study reported global decreases in brain network modularity which correlated with antidepressant response. One ayahuasca study reported increased activity in the limbic regions following treatment. Preliminary evidence suggests that the default mode and limbic networks may be a target for future research on the neural mechanisms of psychedelics. More data is required to corroborate these initial findings as the evidence summarized in this review is based on four datasets.https://doi.org/10.1177/24705470221115342
spellingShingle Sarah Kuburi
Anne-Marie Di Passa
Vanessa K. Tassone
Raesham Mahmood
Aleksandra Lalovic
Karim S. Ladha
Katharine Dunlop
Sakina Rizvi
Ilya Demchenko
Venkat Bhat
Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
Chronic Stress
title Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
title_full Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
title_fullStr Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
title_full_unstemmed Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
title_short Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
title_sort neuroimaging correlates of treatment response with psychedelics in major depressive disorder a systematic review
url https://doi.org/10.1177/24705470221115342
work_keys_str_mv AT sarahkuburi neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT annemariedipassa neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT vanessaktassone neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT raeshammahmood neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT aleksandralalovic neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT karimsladha neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT katharinedunlop neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT sakinarizvi neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT ilyademchenko neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview
AT venkatbhat neuroimagingcorrelatesoftreatmentresponsewithpsychedelicsinmajordepressivedisorderasystematicreview